John Spillane
Impact in
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- Bone health and treatments
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Dermatology top 10%
Papers in
- Oncology 18
- Cutaneous Melanoma Detection and Management 14
- Cancer Cells and Metastasis 2
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 2
-
- Melanoma and MAPK Pathways 7
- Co-authors
- Michael A. Henderson (17 shared papers)David Gyorki (13 shared papers)David Speakman (12 shared papers)Janine A. Danks (1 shared paper)John L. Hopper (1 shared paper)Peter Choong (1 shared paper)T. John Martin (1 shared paper)Graham Byrnes (1 shared paper)
- Journals
- Annals of Surgical Oncology (5 papers)ANZ Journal of Surgery (4 papers)Journal of Clinical Oncology (2 papers)Journal of Surgical Oncology (2 papers)Head & Neck (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
John Spillane
23 papers receiving 360 citations
Peers
Comparison fields: 5 of 71
- Oncology 280
- Dermatology 40
- Molecular Biology 148
- Immunology 43
- Cancer Research 25
Countries citing papers authored by John Spillane
This map shows the geographic impact of John Spillane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Spillane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Spillane more than expected).
Fields of papers citing papers by John Spillane
This network shows the impact of papers produced by John Spillane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Spillane. The network helps show where John Spillane may publish in the future.
Co-authors
The 25 scholars most cited alongside John Spillane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 92 | |
| 2 | 2007 | 61 | |
| 3 | 2016 | 24 | |
| 4 | 2016 | 23 | |
| 5 | 2016 | 22 | |
| 6 | 2015 | 20 | |
| 7 | 2015 | 19 | |
| 8 | 2018 | 15 | |
| 9 | 2016 | 13 | |
| 10 | 2014 | 12 | |
| 11 | 2012 | 10 | |
| 12 | 1998 | 9 | |
| 13 | 2016 | 9 | |
| 14 | 2016 | 8 | |
| 15 | 2023 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2002 | 5 | |
| 19 | 2015 | 4 | |
| 20 | 2015 | 2 |
About John Spillane
John Spillane is a scholar working on Oncology, Molecular Biology, Surgery, Epidemiology and Genetics, having authored 23 papers that have together received 369 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (14 papers), Melanoma and MAPK Pathways (7 papers), Nonmelanoma Skin Cancer Studies (4 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Esophageal and GI Pathology (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (280 citations), Dermatology (40 citations), Molecular Biology (148 citations), Immunology (43 citations) and Cancer Research (25 citations). John Spillane has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Michael A. Henderson, David Gyorki, David Speakman, Janine A. Danks, John L. Hopper, Peter Choong, T. John Martin, Graham Byrnes, John Slavin and Angela Webb. Their work appears in journals such as Annals of Surgical Oncology, ANZ Journal of Surgery, Journal of Clinical Oncology, Journal of Surgical Oncology and Head & Neck.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.